Saneca Pharma has announced the appointment of its new chief executive officer, Richard Král.

Richard, who has been the sales and marketing director at Saneca for almost three years, has previously worked for GlaxoSmithKline and Zentiva Group.

As chief executive officer, he will be responsible for implementing Saneca’s business growth strategy, driving operational efficiency and ensuring effective project delivery across the business.

Richard Král, said, “I am delighted to be appointed as CEO of Saneca. Over the last three years I have developed a comprehensive understanding of the company and I am looking forward to continuing to drive its success and establishing Saneca as the go-to CDMO in Europe. “

Based in western Slovakia, in close proximity to Vienna, Saneca Pharma offers its customers strong capabilities in solids, semi-solids and liquids, as well as specialist expertise in the development and manufacture of opiate active pharmaceutical ingredients (APIs) and finished dosage forms from farm to pharmacy.